Improved Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease in Denmark
Authors:
- Bjarne OrskovBOBjarne Orskov
- Vibeke Rømming SørensenVSVibeke Rømming Sørensen
- Bo Feldt-RasmussenBFBo Feldt-Rasmussen
Open Access
- 1 November 2010
- journal article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 5 (11) , 2034-2039
Abstract
Background and objectives: The introduction of new therapies, including agents that block the renin-angiotensin system, may have affected progression of autosomal dominant polycystic kidney disease (ADPKD). We investigated whether the age when reaching ESRD and survival during renal replacement therapy in Danish patients with ADPKD changed from January 1, 1990, through December 31, 2007. Design, setting, participants, & measurements: According to the Danish National Registry on Regular Dialysis and Transplantation, 693 patients with ADPKD reached ESRD in the study period. The 18 years were divided into three consecutive 6-year intervals. Results: The incidence of reaching ESRD for patients with ADPKD increased from 6.45 per million people in 1990 through 1995 to 7.59 per million people in 2002 through 2007, and the mean age at onset of ESRD increased by 4.7 years. The age-adjusted male-to-female ratio for onset of ESRD changed from 1.6 to 1.1, indicating a trend toward similar progression in both genders. From onset of ESRD, a Cox regression analysis to compare the first and second 6-year intervals, adjusted for age, gender, and treatment modality, showed that patient survival improved by 38%. Although NS, a similar trend was found during the second and third time intervals. Conclusions: This study demonstrates that in Danish patients with ADPKD, the prognosis had significantly improved during the study period. Furthermore, the results indicate that male gender may be losing its importance as a risk factor for progression in ADPKD.Keywords
This publication has 29 references indexed in Scilit:
- Autosomal dominant polycystic kidney disease: the last 3 yearsKidney International, 2009
- Improvement of Endothelial Dysfunction with Simvastatin in Patients with Autosomal Dominant Polycystic Kidney DiseaseRenal Failure, 2007
- Review: Autosomal Dominant Polycystic Kidney Disease: Role of the Renin-Angiotensin System in Raised Blood Pressure in Progression of Renal and Cardiovascular DiseaseJournal of the Renin-Angiotensin-Aldosterone System, 2006
- Incident Renal Events and Risk Factors in Autosomal Dominant Polycystic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2006
- Stabilized incidence of diabetic patients referred for renal replacement therapy in DenmarkKidney International, 2006
- The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney diseaseKidney International, 2005
- The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney diseaseAmerican Journal of Physiology-Renal Physiology, 2004
- Epidemiological study of kidney survival in autosomal dominant polycystic kidney diseaseKidney International, 2003
- Comparison of phenotypes of polycystic kidney disease types 1 and 2The Lancet, 1999
- Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney diseaseKidney International, 1992